Gardasil cheaper


gardasilDrug company CSL will today cut its asking price for cervical cancer vaccine Gardasil in a renewed bid to secure public subsidies.

CSL chief executive Brian McNamee has cut short a trip to the US to attend a meeting with Department of Health officials in the hope of reversing last week's rejection of the vaccine's listing on the pharmaceutical benefits scheme.

The vaccine, developed by Australian of the Year Ian Frazer, protects women against cervical cancer.

source - The Australian News